Biocom’s 5th Annual Global Life Science Partnering Conference, February 25-26, 2015, The Lodge at Torrey Pines, La Jolla, California
Reporter: Aviva Lev-Ari, PhD, RN
The Premier Partnering Event of 2015
Biocom’s 5th Annual Global Life Science Partnering Conference is an exclusive global partnering and networking forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies.
The conference will include panel discussions on relevant topics with senior industry leaders, individual company presentations, one-on-one meetings, and numerous networking opportunities.
Wednesday, February 25, 2015 – Thursday, February 26, 2015
8:00 a.m. – 5:00 p.m.
CLICK HERE TO REGISTER
RSVP by: Monday, February 23, 2015 12:00 p.m.
Where: The Lodge at Torrey Pines
11480 North Torrey Pines Road
La Jolla, California 92037
CLICK HERE TO REGISTER
Partnering Forum scheduling will open on Monday, January 19th! Register today and begin updating your company profile. More details HERE!
We are in the process of accepting company applications. If your company is interested in presenting during the conference, click HERE to download the application.
Confirmed Speakers
Karen Bernstein, Chairman & Editor-in-Chief, BioCentury
Miranda Biven, Partner, Technology Transactions Intellectual Property, Wilson Sonsini Goodrich & Rosati
Richard Brudnick, SVP of Corporate Development, Biogen Idec
Dan Burgess, Former CEO,
Rempex Pharmaceuticals
Bharatt Chowrira, Chief Operating Officer,
Auspex Pharmaceuticals
Iain Dukes, SVP, Licensing & External Science, Merck
Carol Gallagher, Partner, New Enterprise Associates, Inc. (NEA)
George Golumbeski, SVP, Business Development, Celgene
Mike Grey, Former President & CEO, Lumena Pharmaceuticals Inc.; Venture Partner at Pappas Ventures
Chris Haskell, Head, US Science Hub, Global External Innovation & Alliances, Bayer Healthcare
Rich Heyman, CEO, Seragon Pharmaceuticals
Nancy Hong, Senior Associate, BioMed Ventures
David Kabakoff, Executive Partner, Sofinnova Ventures
Adam Keeney, Global Head, External Innovation, Sanofi
Cheston Larson, Partner, Latham & Watkins LLP
Heath Lukatch, Partner, Novo Ventures
Michael Martino, President & CEO, Ambit Biosciences
Damien McDevitt Ph.D., VP Business Development & Head of R&D West Coast, GlaxoSmithKline
Carole Neuchterlein, Head, Roche Venture Fund
Naoki Okamura, Corporate Vice President, Global Head of Business Development, Astellas Pharma
Neela Patel, Director, Licensing – Search & Evaluation, AbbVie
Ed Saltzman, President & Founder, Defined Health
Corinne Savill, Head of Business Development and Licensing, Novartis
Ted Schroeder, CEO, Cadence Pharmaceuticals
Peter Schultz, Professor of Chemistry, The California Institute for Biomedical Research, The Scripps Research Institute
David Shapiro, Exec VP, Development & Chief Medical Officer, Intercept Pharmaceuticals
Bob Smith, SVP, Business Development, Worldwide Research & Development, Pfizer
Barbara Sosnowski, Vice President, External R&D Innovation, Pfizer
Jack Tupman, VP, Corporate Business Development, Eli Lilly
Jeffrey W. Warmke, SVP, External Scientific Affairs, Daiichi Sankyo Group
Bradley B. Wolff, Managing Director, Senior Investment Banker, Bank of America Merrill Lynch
David Weber, CEO, President & Board Member, Otonomy
Samuel Wu, Managing Director, MedImmune Ventures
Leave a Reply